Logo image of CGX-DB-B.CA

CINEPLEX INC (CGX-DB-B.CA) Stock Price, Quote, News and Overview

TSX:CGX-DB-B - Toronto Stock Exchange - CA172454AC48 - Currency: CAD

130.03  -3.27 (-2.45%)

Fundamental Rating

3

CGX-DB-B gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 14 industry peers in the Entertainment industry. CGX-DB-B has a medium profitability rating, but doesn't score so well on its financial health evaluation. CGX-DB-B has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CGX-DB-B had negative earnings in the past year.
In the past year CGX-DB-B had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CGX-DB-B reported negative net income in multiple years.
CGX-DB-B had a positive operating cash flow in 4 of the past 5 years.
CGX-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCGX-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CGX-DB-B has a Return On Assets of -3.71%. This is in the better half of the industry: CGX-DB-B outperforms 78.57% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.19%, CGX-DB-B belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGX-DB-B is in line with the industry average of 3.76%.
Industry RankSector Rank
ROA -3.71%
ROE N/A
ROIC 3.19%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
CGX-DB-B.CA Yearly ROA, ROE, ROICCGX-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

CGX-DB-B has a better Operating Margin (5.69%) than 92.86% of its industry peers.
In the last couple of years the Operating Margin of CGX-DB-B has declined.
CGX-DB-B has a Gross Margin of 67.17%. This is amongst the best in the industry. CGX-DB-B outperforms 92.86% of its industry peers.
CGX-DB-B's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.69%
PM (TTM) N/A
GM 67.17%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
CGX-DB-B.CA Yearly Profit, Operating, Gross MarginsCGX-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

CGX-DB-B has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CGX-DB-B has been reduced compared to 1 year ago.
CGX-DB-B has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, CGX-DB-B has an improved debt to assets ratio.
CGX-DB-B.CA Yearly Shares OutstandingCGX-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGX-DB-B.CA Yearly Total Debt VS Total AssetsCGX-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.07 indicates that CGX-DB-B is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.07, CGX-DB-B belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CGX-DB-B has a debt to FCF ratio of 111.23. This is a negative value and a sign of low solvency as CGX-DB-B would need 111.23 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 111.23, CGX-DB-B is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 111.23
Altman-Z 2.07
ROIC/WACC0.44
WACC7.28%
CGX-DB-B.CA Yearly LT Debt VS Equity VS FCFCGX-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CGX-DB-B has a Current Ratio of 0.25. This is a bad value and indicates that CGX-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CGX-DB-B (0.25) is worse than 64.29% of its industry peers.
CGX-DB-B has a Quick Ratio of 0.25. This is a bad value and indicates that CGX-DB-B is not financially healthy enough and could expect problems in meeting its short term obligations.
CGX-DB-B's Quick ratio of 0.21 is on the low side compared to the rest of the industry. CGX-DB-B is outperformed by 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.21
CGX-DB-B.CA Yearly Current Assets VS Current LiabilitesCGX-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for CGX-DB-B have decreased strongly by -412.50% in the last year.
Looking at the last year, CGX-DB-B shows a decrease in Revenue. The Revenue has decreased by -3.18% in the last year.
The Revenue has been decreasing by -4.39% on average over the past years.
EPS 1Y (TTM)-412.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-825%
Revenue 1Y (TTM)-3.18%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.34%

3.2 Future

Based on estimates for the next years, CGX-DB-B will show a very strong growth in Earnings Per Share. The EPS will grow by 88.17% on average per year.
The Revenue is expected to grow by 5.40% on average over the next years.
EPS Next Y178.75%
EPS Next 2Y88.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.77%
Revenue Next 2Y6.11%
Revenue Next 3Y5.4%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGX-DB-B.CA Yearly Revenue VS EstimatesCGX-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CGX-DB-B.CA Yearly EPS VS EstimatesCGX-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

CGX-DB-B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 143.05, the valuation of CGX-DB-B can be described as expensive.
CGX-DB-B's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CGX-DB-B is cheaper than 64.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CGX-DB-B to the average of the S&P500 Index (35.19), we can say CGX-DB-B is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 143.05
CGX-DB-B.CA Price Earnings VS Forward Price EarningsCGX-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CGX-DB-B is valued a bit cheaper than 64.29% of the companies in the same industry.
CGX-DB-B's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CGX-DB-B is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 505.41
EV/EBITDA 40.22
CGX-DB-B.CA Per share dataCGX-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

CGX-DB-B's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CGX-DB-B's earnings are expected to grow with 88.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y88.17%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CGX-DB-B does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CINEPLEX INC

TSX:CGX-DB-B (7/9/2025, 7:00:00 PM)

130.03

-3.27 (-2.45%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners29.68%
Inst Owner ChangeN/A
Ins Owners1.98%
Ins Owner ChangeN/A
Market Cap8.25B
Analysts78
Price Target152.01 (16.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-58.05%
Min EPS beat(2)-87.06%
Max EPS beat(2)-29.05%
EPS beat(4)1
Avg EPS beat(4)-125.97%
Min EPS beat(4)-413.09%
Max EPS beat(4)25.32%
EPS beat(8)3
Avg EPS beat(8)-654.2%
EPS beat(12)6
Avg EPS beat(12)-390.53%
EPS beat(16)7
Avg EPS beat(16)-297.94%
Revenue beat(2)0
Avg Revenue beat(2)-4.99%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-4.59%
Revenue beat(4)1
Avg Revenue beat(4)-2.71%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)-7.57%
Revenue beat(12)8
Avg Revenue beat(12)-4.2%
Revenue beat(16)11
Avg Revenue beat(16)-2.39%
PT rev (1m)0%
PT rev (3m)-11.21%
EPS NQ rev (1m)496.49%
EPS NQ rev (3m)246.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-20.69%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 143.05
P/S 6.34
P/FCF 505.41
P/OCF 82.1
P/B N/A
P/tB N/A
EV/EBITDA 40.22
EPS(TTM)-1.25
EYN/A
EPS(NY)0.91
Fwd EY0.7%
FCF(TTM)0.26
FCFY0.2%
OCF(TTM)1.58
OCFY1.22%
SpS20.49
BVpS-1.17
TBVpS-12.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.71%
ROE N/A
ROCE 4.43%
ROIC 3.19%
ROICexc 3.23%
ROICexgc 5.61%
OM 5.69%
PM (TTM) N/A
GM 67.17%
FCFM 1.26%
ROA(3y)1.91%
ROA(5y)-6.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.36%
ROIC(5y)N/A
ROICexc(3y)3.46%
ROICexc(5y)N/A
ROICexgc(3y)5.89%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y2.1%
ROICexc growth 3YN/A
ROICexc growth 5Y0.06%
OM growth 3YN/A
OM growth 5Y-3.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.02%
GM growth 5Y0.37%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 111.23
Debt/EBITDA 6.88
Cap/Depr 47.87%
Cap/Sales 6.47%
Interest Coverage 0.54
Cash Conversion 40.23%
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.21
Altman-Z 2.07
F-Score4
WACC7.28%
ROIC/WACC0.44
Cap/Depr(3y)39.73%
Cap/Depr(5y)33.4%
Cap/Sales(3y)5.83%
Cap/Sales(5y)8.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-412.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-825%
EPS Next Y178.75%
EPS Next 2Y88.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.18%
Revenue growth 3Y26.54%
Revenue growth 5Y-4.39%
Sales Q2Q%-10.34%
Revenue Next Year6.77%
Revenue Next 2Y6.11%
Revenue Next 3Y5.4%
Revenue Next 5YN/A
EBIT growth 1Y-45.4%
EBIT growth 3YN/A
EBIT growth 5Y-7.81%
EBIT Next Year216.27%
EBIT Next 3Y55.93%
EBIT Next 5Y28.45%
FCF growth 1Y-51.94%
FCF growth 3Y41.4%
FCF growth 5Y-13.75%
OCF growth 1Y-13.19%
OCF growth 3Y38.48%
OCF growth 5Y-12.79%